Weight Loss Innovation
PinnoThin works by stimulating the release of two hunger-suppressing peptide hormones, CCK (cholecystokinin) and GLP1 (glucagon-like peptide 1), which send signals of satiation to the brain, significantly decreasing the desire to eat.
Obesity is set to replace smoking as the biggest cause of heart disease in the twenty-first century – unless current unhealthy dietary and lifestyle trends are changed.
Obesity also increases the risks of a whole range of other diseases, including Type 2 diabetes, stroke, kidney failure, gallbladder disease, hypertension and cancer. In the United States today almost one third of the entire adult population is obese, and Western Europe is catching up fast.
But obesity is also on the rise in the developing world. In the face of this global problem, governments, doctors and scientists have all been looking for ways to combat obesity. There is clearly a market for food additives and dietary supplements that help tackle this increasing threat to people’s health.
The food industry has been busy for some time developing ‘diet’ or ‘light’ products to help people reduce their caloric intake. But these products often fail to make people feel full, which then leads to further unhealthy snacking behaviour. Now Lipid Nutrition, a division of Loders Croklaan has developed PinnoThin a revolutionary new dietary supplement. It works on the very simple premise of ‘What you don’t eat now, you won’t need to lose later!’ In fact, it stimulates the production of hormones that naturally suppress the desire to eat, preventing weight gain at the source. If taken 30-60 minutes before a meal, it is an effective tool in as appetite suppressant. It can also be taken between meals to prevent the hungry feeling that leads to snacking. The beneficial effects of PinnoThin have been demonstrated at a supplemental dosage of 3g. PinnoThin is 100% natural and offers a safe, simple and effective way to reduce excessive caloric intake.
The active ingredient of PinnoThin is pinolenic acid, which is found in various pine kernels. Unlike many pine seeds, which often contain very low levels of pinolenic acid, the seeds used for manufacturing PinnoThin come from the native Korean pine (Pinus korariensis) and naturally contain very high levels of pinolenic acid. PinnoThin works by stimulating the release of two hunger-suppressing peptide hormones, CCK (cholecystokinin) and GLP1 (glucagon-like peptide 1), which send signals of satiation to the brain, significantly decreasing the desire to eat.
Clinical trials have already confirmed the effectiveness of PinnoThin. When Lipid Nutrition tested PinnoThin in a randomised, double blind cross-over trial, the result was immediately apparent: PinnoThin indeed suppresses appetite and promotes a feeling of fullness. Thirty minutes after having taken a 3g dose of PinnoThin, the test subjects reported significantly less desire to eat than subjects who had taken an olive oil placebo. Within 30-60 minutes, PinnoThin had also significantly increased the amount of CCK and GLP1 hormones in the blood. By increasing the levels of these hormones, PinnoThin promotes a feeling of satiation and could effectively reduce food intake.
PinnoThin is available in free fatty acid (FFA) form as well as triglyceride (TG) form, and is suitable for use in a whole variety of applications, from dietary supplements to foods and beverages.
With PinnoThin, Lipid Nutrition has not only come up with a powerful weapon in the fight against obesity, but has also provided a versatile and desirable ingredient that will help food and dietary supplement manufacturers to extend their ranges and expand their markets.
www.lipidnutrition.com
